Dongdong Yu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Ulcerative Colitis

Multiple Myeloma

Intensive Care Unit

Top Venues

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Dongdong Yu, Ting Cheng, Tong Liu, Wenjun Xu, Dawei Liu, Jinzhi Dai, Shanshan Cai, Yuxiang Guan, Ting Ye, Xiaoyu Cheng
Safety of proteasome inhibitor drugs for the treatment of multiple myeloma post-marketing: a pharmacovigilance investigation based on the FDA adverse event reporting system. Expert opinion on drug safety (2024)
Dongdong Yu, Ting Cheng, Tong Liu, Wenjun Xu, Dawei Liu, Jinzhi Dai, Shanshan Cai, Yuxiang Guan, Ting Ye, Xiaoyu Cheng
Safety of proteasome inhibitor drugs for the treatment of multiple myeloma post-marketing: a pharmacovigilance investigation based on the FDA adverse event reporting system. Expert opinion on drug safety (2024)